Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Open access
Guan, Wei-jie, Liang, Wen-hua, Zhao, Yi, Liang, Heng-rui, Chen, Zi-sheng, Li, Yi-min, Liu, Xiao-qing, Chen, Ru-chong, Tang, Chun-li, Wang, Tao, Ou, Chun-quan, Li, Li, Chen, Ping-yan, Sang, Ling, Wang, Wei, Li, Jian-fu, Li, Cai-chen, Ou, Li-min, Cheng, Bo, Xiong, Shan, Ni, Zheng-yi, Xiang, Jie, Hu, Yu, Liu, Lei, Shan, Hong, Lei, Chun-liang, Peng, Yi-xiang, Wei, Li, Liu, Yong, Hu, Ya-hua, Peng, Peng, Wang, Jian-ming, Liu, Ji-yang, Chen, Zhong, Li, Gang, Zheng, Zhi-jian, Qiu, Shao-qin, Luo, Jie, Ye, Chang-jiang, Zhu, Shao-yong, Cheng, Lin-ling, Ye, Feng, Li, Shi-yue, Zheng, Jin-ping, Zhang, Nuo-fu, Zhong, Nan-shan, He, Jian-xing · 2020 · European Respiratory Journal

Published version of a preprint

Abstract

Background: The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly worldwide. Objective: To evaluate the risk of serious adverse outcomes in patients with COVID-19 by stratifying the comorbidity status. Methods: We analysed data from 1590 laboratory confirmed hospitalised patients from 575 hospitals in 31 provinces/autonomous regions/provincial municipalities across mainland China between 11 December 2019 and 31 January 2020. We analysed the composite end-points, which consisted of admission to an intensive care unit, invasive ventilation or death. The risk of reaching the composite end-points was compared according to the presence and number of comorbidities. Results: The mean age was 48.9 years and 686 (42.7%) patients were female. Severe cases accounted for 16.0% of the study population. 131 (8.2%) patients reached the composite end-points. 399 (25.1%) reported having at least one comorbidity. The most prevalent comorbidity was hypertension (16.9%), followed by diabetes (8.2%). 130 (8.2%) patients reported having two or more comorbidities. After adjusting for age and smoking status, COPD (HR (95% CI) 2.681 (1.424–5.048)), diabetes (1.59 (1.03–2.45)), hypertension (1.58 (1.07–2.32)) and malignancy (3.50 (1.60–7.64)) were risk factors of reaching the composite end-points. The hazard ratio (95% CI) was 1.79 (1.16–2.77) among patients with at least one comorbidity and 2.59 (1.61–4.17) among patients with two or more comorbidities. Conclusion: Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.00547-2020

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 a) The time-dependent risk of reaching the composite end-points between patients with or without any comorbidity. b) The time-dependent risk of reaching the composite end-points between patients without any comorbidity, patients with a single comorbidity and patients with two or more comorbidities. Cox proportional hazard regression models were applied to determine the potential risk factors associated with the composite end-points, with the hazard ratio and 95% confidence interval being reported.
FIGURE 1 a) The time-dependent risk of reaching the composite end-points between patients with or without any comorbidity. b) The time-dependent risk of reaching the composite end-points between patients without any comorbidity, patients with a single comorbidity and patients with two or more comorbidities. Cox proportional hazard regression models were applied to determine the potential risk factors associated with the composite end-points, with the hazard ratio and 95% confidence interval being reported.CC BY-NC · PubMed Central
FIGURE 2 Predictors of the composite end-points in the proportional hazards model. Hazard ratio (95% confidence interval) are shown for the risk factors associated with the composite end-points (admission to intensive care unit, invasive ventilation or death). The comorbidities were classified according to the organ systems as well as the number. The scale bar indicates the hazard ratio. Cox proportional hazard regression models were applied to determine the potential risk factors associated with the composite end-points, with the hazard ratio (95% confidence interval) being reported. The model has been adjusted with age and smoking status.
FIGURE 2 Predictors of the composite end-points in the proportional hazards model. Hazard ratio (95% confidence interval) are shown for the risk factors associated with the composite end-points (admission to intensive care unit, invasive ventilation or death). The comorbidities were classified according to the organ systems as well as the number. The scale bar indicates the hazard ratio. Cox proportional hazard regression models were applied to determine the potential risk factors associated with the composite end-points, with the hazard ratio (95% confidence interval) being reported. The model has been adjusted with age and smoking status.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 3,680

Metadata

Authors
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., Ou, C.-Q., Li, L., Chen, P.-Y., Sang, L., Wang, W., Li, J.-F., Li, C.-C., Ou, L.-M., Cheng, B., Xiong, S., Ni, Z.-Y., Xiang, J., Hu, Y., Liu, L., Shan, H., Lei, C.-L., Peng, Y.-X., Wei, L., Liu, Y., Hu, Y.-H., Peng, P., Wang, J.-M., Liu, J.-Y., Chen, Z., Li, G., Zheng, Z.-J., Qiu, S.-Q., Luo, J., Ye, C.-J., Zhu, S.-Y., Cheng, L.-L., Ye, F., Li, S.-Y., Zheng, J.-P., Zhang, N.-F., Zhong, N.-S., & He, J.-X.
Affiliations
  • First Affiliated Hospital of Guangzhou Medical University (CN)
  • Southern Medical University (CN)
  • Jinyintan Hospital (CN)
  • Hubei Polytechnic University (CN)
  • Southern University of Science and Technology (CN)
  • Fifth Affiliated Hospital of Sun Yat-sen University (CN)
  • Central Hospital of Wuhan (CN)
  • Wuhan No.1 Hospital (CN)
  • Public Health Clinical Center of Chengdu (CN)
  • Wuhan Pulmonary Hospital (CN)
  • Wuhan University of Science and Technology (CN)
  • Huanggang Central Hospital (CN)
  • The First People's Hospital of Wenling (CN)
  • Hubei University of Medicine (CN)
Corresponding author
He, Jian-xing
Venue
European Respiratory Journal
Published
2020-03-26
Volume
55
Issue
5
Pages
2000547
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W3013125498
Cited by
3,680
References
35
Citations by year
2026: 26 · 2025: 73 · 2024: 185 · 2023: 362 · 2022: 603 · 2021: 1142 · 2020: 1281
FWCI
110.51
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion, cc-by-nc)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by-nc)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
Funders
  • National Health Commission (NA)
  • Guangdong Science and Technology Department (NA)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, comorbidities, comorbidity burden, clinical outcomes, intensive care unit admission, invasive mechanical ventilation, mortality, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, cancer, risk factors, hospitalized patients
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Adult, China, Female, Humans, Male, Middle Aged, Pneumonia, Viral, Prognosis, Risk Factors, Comorbidity, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.